Target Professions: | DO, MD, Nurse, Nurse Practitioner, Physician Assistant |
Target Specialties: | Allergy and Immunology, Adolescent Medicine, Dermatology, Epidemiology, Family Medicine, Internal Medicine, Pediatrics |
Credits Available: | 2.50 AMA PRA Category 1 Credit™ |
Clinically heterogeneous presentation, with only intermittent symptoms and long latent periods for some patients, along with manifestations that overlap with other skin conditions make the diagnosis of atopic dermatitis difficult for clinicians, resulting in delays in diagnosis and treatment. Current therapies such as topical corticosteroids, emollients, supportive care and biologics have limited efficacy and are not adequate for treating many patients with moderate to severe AD across different skin types. To bridge this gap, novel targeted therapies are needed. Investigational therapies such as Janus Kinase 1 (JAK 1) inhibitors, monoclonal antibodies, and membrane IgE inhibitor when approved will transform the treatment approaches for AD. These advancements will provide more treatment options for patients and will allow clinicians to specifically treat underlying causes of AD with more certainty. However, substantial accumulation of new data from these advances creates knowledge and practice gaps that affect patient care. This collaborative social learning platform establishes a network of providers who can support each other locally, as well as those from different communities, with the goal of learning and sharing best practices that will improve outcomes for patients.
The following questions are designed to assess your knowledge and practice of patients with atopic dermatitis.
This module will present considerations for diagnosing and managing atopic dermatitis in the pediatric population.
This module will present considerations for diagnosing and managing atopic dermatitis in the adult population.
The following questions are designed to assess your knowledge and practice of patients with atopic dermatitis.
Please join me for a brief kick off where you'll have a chance to greet other group members and discuss our collective goals and priorities for the next few weeks. I’m really looking forward to seeing you.
This virtual live discussion provides an opportunity for the group to convene with their group leader to discuss aspects of the self-study learning modules.
This virtual live discussion provides an opportunity for the group to convene with their group leader to discuss aspects of the case study responses and action plans.
This group task activity has been designed for the learner to explore a patient case study and to apply the knowledge they have learned throughout the activity to determine the most appropriate way to treat the patient.
This group task activity has been designed for the learner to explore a patient case study and to apply the knowledge they have learned throughout the activity to determine the most appropriate way to treat the patient.
This group task activity has been designed for the learner to explore a patient case study and to apply the knowledge they have learned throughout the activity to determine the most appropriate way to treat the patient.
In light of the information reviewed and discussed during this program, can you share an action plan that you will implement to improve the outcomes for your patients with atopic dermatitis.
Thank you for your interest. Currently, the curriculum is closed for enrollment but we encourage you to keep an eye out for future opportunities or alternative programs that might align with your educational goals.